Clinical Trials Browser

Phase 2 × NX-13 × Clear all

NCT05785715 2025-07-01

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Phase 2 Terminated

Colitis, Ulcerative, Lymphoma, Follicular